ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Vaccine for Non-infectious Meningitis Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-15R7887
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Vaccine for Non infectious Meningitis Market Insights and Forecast to 2028
BUY CHAPTERS

Global Vaccine for Non-infectious Meningitis Market Research Report 2025

Code: QYRE-Auto-15R7887
Report
September 2025
Pages:68
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Serum Institute
Sanofi SA
Pfizer Inc
Nuron Biotech
JN-International Medical

Vaccine for Non-infectious Meningitis Market Size

The global market for Vaccine for Non-infectious Meningitis was valued at US$ 1.3 million in the year 2024 and is projected to reach a revised size of US$ 2.7 million by 2031, growing at a CAGR of 12.0% during the forecast period.

Vaccine for Non-infectious Meningitis Market

Vaccine for Non-infectious Meningitis Market

Meningococcal conjugate vaccine is used to prevent infection caused by meningococcal bacteria.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vaccine for Non-infectious Meningitis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine for Non-infectious Meningitis.
The Vaccine for Non-infectious Meningitis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vaccine for Non-infectious Meningitis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine for Non-infectious Meningitis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Vaccine for Non-infectious Meningitis Market Report

Report Metric Details
Report Name Vaccine for Non-infectious Meningitis Market
Accounted market size in year US$ 1.3 million
Forecasted market size in 2031 US$ 2.7 million
CAGR 12.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Meningitis
  • Septicemia
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Serum Institute, Sanofi SA, Pfizer, Nuron Biotech, JN-International Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Vaccine for Non-infectious Meningitis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Vaccine for Non-infectious Meningitis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Vaccine for Non-infectious Meningitis Market growing?

Ans: The Vaccine for Non-infectious Meningitis Market witnessing a CAGR of 12.0% during the forecast period 2025-2031.

What is the Vaccine for Non-infectious Meningitis Market size in 2031?

Ans: The Vaccine for Non-infectious Meningitis Market size in 2031 will be US$ 2.7 million.

Who are the main players in the Vaccine for Non-infectious Meningitis Market report?

Ans: The main players in the Vaccine for Non-infectious Meningitis Market are Serum Institute, Sanofi SA, Pfizer, Nuron Biotech, JN-International Medical

What are the Application segmentation covered in the Vaccine for Non-infectious Meningitis Market report?

Ans: The Applications covered in the Vaccine for Non-infectious Meningitis Market report are Meningitis, Septicemia, Others

What are the Type segmentation covered in the Vaccine for Non-infectious Meningitis Market report?

Ans: The Types covered in the Vaccine for Non-infectious Meningitis Market report are Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Men B Vaccines

Recommended Reports

Meningitis and Meningococcal

Vaccine Technologies

Other Vaccine Markets

1 Vaccine for Non-infectious Meningitis Market Overview
1.1 Product Definition
1.2 Vaccine for Non-infectious Meningitis by Type
1.2.1 Global Vaccine for Non-infectious Meningitis Market Value Comparison by Type (2024 VS 2031)
1.2.2 Polysaccharide Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Combination Vaccines
1.2.5 Men B Vaccines
1.3 Vaccine for Non-infectious Meningitis by Application
1.3.1 Global Vaccine for Non-infectious Meningitis Market Value by Application (2024 VS 2031)
1.3.2 Meningitis
1.3.3 Septicemia
1.3.4 Others
1.4 Global Vaccine for Non-infectious Meningitis Market Size Estimates and Forecasts
1.4.1 Global Vaccine for Non-infectious Meningitis Revenue 2020-2031
1.4.2 Global Vaccine for Non-infectious Meningitis Sales 2020-2031
1.4.3 Global Vaccine for Non-infectious Meningitis Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Vaccine for Non-infectious Meningitis Market Competition by Manufacturers
2.1 Global Vaccine for Non-infectious Meningitis Sales Market Share by Manufacturers (2020-2025)
2.2 Global Vaccine for Non-infectious Meningitis Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Vaccine for Non-infectious Meningitis Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Vaccine for Non-infectious Meningitis, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vaccine for Non-infectious Meningitis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccine for Non-infectious Meningitis, Product Type & Application
2.7 Global Key Manufacturers of Vaccine for Non-infectious Meningitis, Date of Enter into This Industry
2.8 Global Vaccine for Non-infectious Meningitis Market Competitive Situation and Trends
2.8.1 Global Vaccine for Non-infectious Meningitis Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Vaccine for Non-infectious Meningitis Players Market Share by Revenue
2.8.3 Global Vaccine for Non-infectious Meningitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vaccine for Non-infectious Meningitis Market Scenario by Region
3.1 Global Vaccine for Non-infectious Meningitis Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Vaccine for Non-infectious Meningitis Sales by Region: 2020-2031
3.2.1 Global Vaccine for Non-infectious Meningitis Sales by Region: 2020-2025
3.2.2 Global Vaccine for Non-infectious Meningitis Sales by Region: 2026-2031
3.3 Global Vaccine for Non-infectious Meningitis Revenue by Region: 2020-2031
3.3.1 Global Vaccine for Non-infectious Meningitis Revenue by Region: 2020-2025
3.3.2 Global Vaccine for Non-infectious Meningitis Revenue by Region: 2026-2031
3.4 North America Vaccine for Non-infectious Meningitis Market Facts & Figures by Country
3.4.1 North America Vaccine for Non-infectious Meningitis Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Vaccine for Non-infectious Meningitis Sales by Country (2020-2031)
3.4.3 North America Vaccine for Non-infectious Meningitis Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vaccine for Non-infectious Meningitis Market Facts & Figures by Country
3.5.1 Europe Vaccine for Non-infectious Meningitis Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Vaccine for Non-infectious Meningitis Sales by Country (2020-2031)
3.5.3 Europe Vaccine for Non-infectious Meningitis Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccine for Non-infectious Meningitis Market Facts & Figures by Region
3.6.1 Asia Pacific Vaccine for Non-infectious Meningitis Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Vaccine for Non-infectious Meningitis Sales by Region (2020-2031)
3.6.3 Asia Pacific Vaccine for Non-infectious Meningitis Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vaccine for Non-infectious Meningitis Market Facts & Figures by Country
3.7.1 Latin America Vaccine for Non-infectious Meningitis Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Vaccine for Non-infectious Meningitis Sales by Country (2020-2031)
3.7.3 Latin America Vaccine for Non-infectious Meningitis Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccine for Non-infectious Meningitis Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccine for Non-infectious Meningitis Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Vaccine for Non-infectious Meningitis Sales by Country (2020-2031)
3.8.3 Middle East and Africa Vaccine for Non-infectious Meningitis Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Vaccine for Non-infectious Meningitis Sales by Type (2020-2031)
4.1.1 Global Vaccine for Non-infectious Meningitis Sales by Type (2020-2025)
4.1.2 Global Vaccine for Non-infectious Meningitis Sales by Type (2026-2031)
4.1.3 Global Vaccine for Non-infectious Meningitis Sales Market Share by Type (2020-2031)
4.2 Global Vaccine for Non-infectious Meningitis Revenue by Type (2020-2031)
4.2.1 Global Vaccine for Non-infectious Meningitis Revenue by Type (2020-2025)
4.2.2 Global Vaccine for Non-infectious Meningitis Revenue by Type (2026-2031)
4.2.3 Global Vaccine for Non-infectious Meningitis Revenue Market Share by Type (2020-2031)
4.3 Global Vaccine for Non-infectious Meningitis Price by Type (2020-2031)
5 Segment by Application
5.1 Global Vaccine for Non-infectious Meningitis Sales by Application (2020-2031)
5.1.1 Global Vaccine for Non-infectious Meningitis Sales by Application (2020-2025)
5.1.2 Global Vaccine for Non-infectious Meningitis Sales by Application (2026-2031)
5.1.3 Global Vaccine for Non-infectious Meningitis Sales Market Share by Application (2020-2031)
5.2 Global Vaccine for Non-infectious Meningitis Revenue by Application (2020-2031)
5.2.1 Global Vaccine for Non-infectious Meningitis Revenue by Application (2020-2025)
5.2.2 Global Vaccine for Non-infectious Meningitis Revenue by Application (2026-2031)
5.2.3 Global Vaccine for Non-infectious Meningitis Revenue Market Share by Application (2020-2031)
5.3 Global Vaccine for Non-infectious Meningitis Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Serum Institute
6.1.1 Serum Institute Company Information
6.1.2 Serum Institute Description and Business Overview
6.1.3 Serum Institute Vaccine for Non-infectious Meningitis Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Serum Institute Vaccine for Non-infectious Meningitis Product Portfolio
6.1.5 Serum Institute Recent Developments/Updates
6.2 Sanofi SA
6.2.1 Sanofi SA Company Information
6.2.2 Sanofi SA Description and Business Overview
6.2.3 Sanofi SA Vaccine for Non-infectious Meningitis Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi SA Vaccine for Non-infectious Meningitis Product Portfolio
6.2.5 Sanofi SA Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Vaccine for Non-infectious Meningitis Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Vaccine for Non-infectious Meningitis Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Nuron Biotech
6.4.1 Nuron Biotech Company Information
6.4.2 Nuron Biotech Description and Business Overview
6.4.3 Nuron Biotech Vaccine for Non-infectious Meningitis Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Nuron Biotech Vaccine for Non-infectious Meningitis Product Portfolio
6.4.5 Nuron Biotech Recent Developments/Updates
6.5 JN-International Medical
6.5.1 JN-International Medical Company Information
6.5.2 JN-International Medical Description and Business Overview
6.5.3 JN-International Medical Vaccine for Non-infectious Meningitis Sales, Revenue and Gross Margin (2020-2025)
6.5.4 JN-International Medical Vaccine for Non-infectious Meningitis Product Portfolio
6.5.5 JN-International Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccine for Non-infectious Meningitis Industry Chain Analysis
7.2 Vaccine for Non-infectious Meningitis Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccine for Non-infectious Meningitis Production Mode & Process Analysis
7.4 Vaccine for Non-infectious Meningitis Sales and Marketing
7.4.1 Vaccine for Non-infectious Meningitis Sales Channels
7.4.2 Vaccine for Non-infectious Meningitis Distributors
7.5 Vaccine for Non-infectious Meningitis Customer Analysis
8 Vaccine for Non-infectious Meningitis Market Dynamics
8.1 Vaccine for Non-infectious Meningitis Industry Trends
8.2 Vaccine for Non-infectious Meningitis Market Drivers
8.3 Vaccine for Non-infectious Meningitis Market Challenges
8.4 Vaccine for Non-infectious Meningitis Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Serum Institute
Sanofi SA
Pfizer Inc
Nuron Biotech
JN-International Medical
List of Tables
 Table 1. Global Vaccine for Non-infectious Meningitis Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Vaccine for Non-infectious Meningitis Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Vaccine for Non-infectious Meningitis Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Vaccine for Non-infectious Meningitis Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Vaccine for Non-infectious Meningitis Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Vaccine for Non-infectious Meningitis Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Vaccine for Non-infectious Meningitis Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Vaccine for Non-infectious Meningitis Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Vaccine for Non-infectious Meningitis, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Vaccine for Non-infectious Meningitis, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Vaccine for Non-infectious Meningitis, Product Type & Application
 Table 12. Global Key Manufacturers of Vaccine for Non-infectious Meningitis, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Vaccine for Non-infectious Meningitis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine for Non-infectious Meningitis as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Vaccine for Non-infectious Meningitis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Vaccine for Non-infectious Meningitis Sales by Region (2020-2025) & (K Units)
 Table 18. Global Vaccine for Non-infectious Meningitis Sales Market Share by Region (2020-2025)
 Table 19. Global Vaccine for Non-infectious Meningitis Sales by Region (2026-2031) & (K Units)
 Table 20. Global Vaccine for Non-infectious Meningitis Sales Market Share by Region (2026-2031)
 Table 21. Global Vaccine for Non-infectious Meningitis Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Region (2020-2025)
 Table 23. Global Vaccine for Non-infectious Meningitis Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Region (2026-2031)
 Table 25. North America Vaccine for Non-infectious Meningitis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Vaccine for Non-infectious Meningitis Sales by Country (2020-2025) & (K Units)
 Table 27. North America Vaccine for Non-infectious Meningitis Sales by Country (2026-2031) & (K Units)
 Table 28. North America Vaccine for Non-infectious Meningitis Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Vaccine for Non-infectious Meningitis Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Vaccine for Non-infectious Meningitis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Vaccine for Non-infectious Meningitis Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Vaccine for Non-infectious Meningitis Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Vaccine for Non-infectious Meningitis Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Vaccine for Non-infectious Meningitis Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Vaccine for Non-infectious Meningitis Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Vaccine for Non-infectious Meningitis Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Vaccine for Non-infectious Meningitis Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Vaccine for Non-infectious Meningitis Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Vaccine for Non-infectious Meningitis Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Vaccine for Non-infectious Meningitis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Vaccine for Non-infectious Meningitis Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Vaccine for Non-infectious Meningitis Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Vaccine for Non-infectious Meningitis Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Vaccine for Non-infectious Meningitis Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Vaccine for Non-infectious Meningitis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Vaccine for Non-infectious Meningitis Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Vaccine for Non-infectious Meningitis Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Vaccine for Non-infectious Meningitis Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Vaccine for Non-infectious Meningitis Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Vaccine for Non-infectious Meningitis Sales (K Units) by Type (2020-2025)
 Table 51. Global Vaccine for Non-infectious Meningitis Sales (K Units) by Type (2026-2031)
 Table 52. Global Vaccine for Non-infectious Meningitis Sales Market Share by Type (2020-2025)
 Table 53. Global Vaccine for Non-infectious Meningitis Sales Market Share by Type (2026-2031)
 Table 54. Global Vaccine for Non-infectious Meningitis Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Vaccine for Non-infectious Meningitis Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Type (2020-2025)
 Table 57. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Type (2026-2031)
 Table 58. Global Vaccine for Non-infectious Meningitis Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Vaccine for Non-infectious Meningitis Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Vaccine for Non-infectious Meningitis Sales (K Units) by Application (2020-2025)
 Table 61. Global Vaccine for Non-infectious Meningitis Sales (K Units) by Application (2026-2031)
 Table 62. Global Vaccine for Non-infectious Meningitis Sales Market Share by Application (2020-2025)
 Table 63. Global Vaccine for Non-infectious Meningitis Sales Market Share by Application (2026-2031)
 Table 64. Global Vaccine for Non-infectious Meningitis Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Vaccine for Non-infectious Meningitis Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Application (2020-2025)
 Table 67. Global Vaccine for Non-infectious Meningitis Revenue Market Share by Application (2026-2031)
 Table 68. Global Vaccine for Non-infectious Meningitis Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Vaccine for Non-infectious Meningitis Price (USD/Unit) by Application (2026-2031)
 Table 70. Serum Institute Company Information
 Table 71. Serum Institute Description and Business Overview
 Table 72. Serum Institute Vaccine for Non-infectious Meningitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Serum Institute Vaccine for Non-infectious Meningitis Product
 Table 74. Serum Institute Recent Developments/Updates
 Table 75. Sanofi SA Company Information
 Table 76. Sanofi SA Description and Business Overview
 Table 77. Sanofi SA Vaccine for Non-infectious Meningitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Sanofi SA Vaccine for Non-infectious Meningitis Product
 Table 79. Sanofi SA Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Vaccine for Non-infectious Meningitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer Vaccine for Non-infectious Meningitis Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Nuron Biotech Company Information
 Table 86. Nuron Biotech Description and Business Overview
 Table 87. Nuron Biotech Vaccine for Non-infectious Meningitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Nuron Biotech Vaccine for Non-infectious Meningitis Product
 Table 89. Nuron Biotech Recent Developments/Updates
 Table 90. JN-International Medical Company Information
 Table 91. JN-International Medical Description and Business Overview
 Table 92. JN-International Medical Vaccine for Non-infectious Meningitis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. JN-International Medical Vaccine for Non-infectious Meningitis Product
 Table 94. JN-International Medical Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Vaccine for Non-infectious Meningitis Distributors List
 Table 98. Vaccine for Non-infectious Meningitis Customers List
 Table 99. Vaccine for Non-infectious Meningitis Market Trends
 Table 100. Vaccine for Non-infectious Meningitis Market Drivers
 Table 101. Vaccine for Non-infectious Meningitis Market Challenges
 Table 102. Vaccine for Non-infectious Meningitis Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Vaccine for Non-infectious Meningitis
 Figure 2. Global Vaccine for Non-infectious Meningitis Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Vaccine for Non-infectious Meningitis Market Share by Type: 2024 & 2031
 Figure 4. Polysaccharide Vaccines Product Picture
 Figure 5. Conjugate Vaccines Product Picture
 Figure 6. Combination Vaccines Product Picture
 Figure 7. Men B Vaccines Product Picture
 Figure 8. Global Vaccine for Non-infectious Meningitis Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Vaccine for Non-infectious Meningitis Market Share by Application: 2024 & 2031
 Figure 10. Meningitis
 Figure 11. Septicemia
 Figure 12. Others
 Figure 13. Global Vaccine for Non-infectious Meningitis Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Vaccine for Non-infectious Meningitis Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Vaccine for Non-infectious Meningitis Sales (2020-2031) & (K Units)
 Figure 16. Global Vaccine for Non-infectious Meningitis Average Price (USD/Unit) & (2020-2031)
 Figure 17. Vaccine for Non-infectious Meningitis Report Years Considered
 Figure 18. Vaccine for Non-infectious Meningitis Sales Share by Manufacturers in 2024
 Figure 19. Global Vaccine for Non-infectious Meningitis Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Vaccine for Non-infectious Meningitis Players: Market Share by Revenue in Vaccine for Non-infectious Meningitis in 2024
 Figure 21. Vaccine for Non-infectious Meningitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Vaccine for Non-infectious Meningitis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Vaccine for Non-infectious Meningitis Sales Market Share by Country (2020-2031)
 Figure 24. North America Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Vaccine for Non-infectious Meningitis Sales Market Share by Country (2020-2031)
 Figure 28. Europe Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Vaccine for Non-infectious Meningitis Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Vaccine for Non-infectious Meningitis Revenue Market Share by Region (2020-2031)
 Figure 36. China Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Vaccine for Non-infectious Meningitis Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Vaccine for Non-infectious Meningitis Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Vaccine for Non-infectious Meningitis Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Vaccine for Non-infectious Meningitis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Vaccine for Non-infectious Meningitis by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Vaccine for Non-infectious Meningitis by Type (2020-2031)
 Figure 58. Global Vaccine for Non-infectious Meningitis Price (USD/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Vaccine for Non-infectious Meningitis by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Vaccine for Non-infectious Meningitis by Application (2020-2031)
 Figure 61. Global Vaccine for Non-infectious Meningitis Price (USD/Unit) by Application (2020-2031)
 Figure 62. Vaccine for Non-infectious Meningitis Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Meningococcal Disease Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Meningococcal Group B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Meningitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Meningococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Meningococcal Meningitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Meningococcal Infections Vaccine Market Insights Forecast to 2030
Global Meningococcal Polysaccharide Vaccine Market Research Report 2025
Global Meningococcal Infections Treatment Market Research Report 2024
Global Meningococcal Group A and C Conjugate Vaccine Market Research Report 2024
Pneumococcal Bacteria Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vaccine Conjugate Market Research Report 2025
Meningococcal Vaccination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prevent Meningitis Vaccine Market Research Report 2025
Global Meningitis Medication Market Research Report 2024
Pneumococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Meningitis Vaccine Market Research Report 2025
Global Pneumococcal Vaccination Market Research Report 2025
Global Group A and C Meningococcal Polysaccharide Vaccine Market Research Report 2024
Global Vaccines For Children Market Insights Forecast to 2030
Meningitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions